Our #PRESTO #Actionchair Professor Elena Adinolfi, will be giving a webinar for the French #purineclub along side two further speakers on Wednesday June 7th, register at: webinarfpc.sciencesconf.org #PRESTO #prestocost2023 #p2xreceptors #therapeutictargets #eucostfunding

Our first ‘meet the researcher’ features Dr Luke Tattersall Dr Luke Tattersall from the Gartland lab The University of Sheffield the research group focuses on targeting #P2Xreceptors in #bone and #bonecancer #invitro & #invivo An example of the research is here ➡️ ncbi.nlm.nih.gov/pmc/articles/P…

Find out about the inaugural #PRESTO meeting, out now in #purinergicsignaling details about the #COSTaction lab groups, models and techniques available to encourage collaboration! COST #publication #research #science #dissemination ➡️ link.springer.com/article/10.100…

60 seconds with a researcher... let’s get down to the nitty-gritty! 🧪⏰ Hear how Dr Luke Tattersall The University of Sheffield is working towards less toxic treatments for osteosarcoma 🧡 To find out more about this research, visit: ow.ly/SuLf50PcOvB #Research #UntilTheresACure

It's a bittersweet day as we say goodbye to our current CEO, Mat Cottle-Shaw! Mat has worked at the Bone Cancer Research Trust for 8 years, creating positive change and hope for the primary bone cancer community. He shares some lasting words with all our supporters 🧡 #TeamBones

The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk mdpi.com/2473104 #mdpiijms via IJMS MDPI

In order to increase awareness, celebrate P2X research and all the hard work of the action… we announce that the 2nd October (2-X) will now be known as The annual P2X Day!!! 🥳🎉🎊🙌🗓 #PRESTO #prestocost2023 #p2xreceptors #therapeutictargets #eucostfunding

Fine margins 🤏 This moment between Lin Yun-Ju and Ma Long is the Best Point of #WTTFrankfurt Day 8 presented by Shuijingfang 🤩🤩🤩 #WTTChampions #PingPong #TableTennis

🚨🚨🚨 Dr. Cécile Delarasse is seeking a highly motivated post-doc to decipher the mechanisms in autoimmune response in Uveitis, a retinal pathology. Expected start date February 2024 #postdoc #Presto #purinergic #retinaldisease

Find out about the second #PRESTO meeting in #Pisa out now in #purinergicsignaling Preclinical and Clinical aspects of P2X receptors as a common route in different diseases COST #publication #research #science #dissemination ➡️ link.springer.com/article/10.100…

Our latest paper is out now in iScience journal lead by Dr. Jennifer Coleman🚨‼️ sciencedirect.com/science/articl…

We show that LARP4 RNA-binding proteins are critical in the growth and spread of osteosarcoma and prostate cancer, and that these proteins (which are often confused with each other!) have very distinct roles in a cellular context.

Dr Luke Tattersall Prof Allie Gartland cell.com/iscience/fullt…

Thanks for submitting your work to our annual meeting! Just don’t forget to register! Early bird discounted rate ends 29th April. Join us in Sheffield this summer Bone Cancer Research Trust CABS

Day 2 of the third PrestoCost Comms meeting on P2X receptors in inflammation and cancer in #Murcia, great to see the early career researchers presenting there work & discussing the next exciting research 🔬 #CostAction #P2X

This week, our supporters had the opportunity to attend a lab tour The University of Sheffield alongside some of our team. A huge THANK YOU to Prof Allie Gartland and her team for sharing their invaluable bone cancer research with us 🧡 Find out more about their research: ow.ly/JZ9F50RuAHm

Our latest ‘meet the researcher’ is Professor Sahil Adriouch from the University of Rouen Normandie, France, their research used AAV Vectors to produce therapeutic Nanobodies #PRESTO #prestocost2024 #p2xreceptors #therapeutictargets #eucostfunding

Otley Run as Michael Van Gerwen Luke Littler & Luke Humphries 😂😂😂😂 🎯🎯🎯

Short interview about our previous Bone Cancer Research Trust funded osteosarcoma research at the latest PrestoCost Comms conference in Ferrara Italy! 🧫🦴🇮🇹

PRESTO would like to honour Professor Francesco Di Virgilio with this recent interview in Ferrara. Professor Di Virgilio sadly passed away suddenly. He will be greatly missed in the purinergic community by friends and colleagues across the world. ➡️ m.youtube.com/watch?v=UJEZRB…